生物来源
mouse
抗体形式
purified antibody
抗体产品类型
primary antibodies
克隆
EDL HMC 1A, monoclonal
种属反应性(根据同源性预测)
all
技术
dot blot: suitable
immunoprecipitation (IP): suitable
同位素/亚型
IgG2bκ
运输
ambient
靶向翻译后修饰
unmodified
一般描述
5-Hydroxymethylcytosine (also known as 5-hmC) is the first oxidative product in the active demethylation of 5-methylcytosine (5mC). 5hmC is a DNA pyrimidine nitrogen base and is a predominantly stable DNA modification. It is produced by the action of three Ten-eleven translocation 1 (TET1) enzyme on 5mC. Each mammalian cell contains 5hmC, but its levels vary significantly depending on the cell type. Higher levels of 5hmC are found in neuronal cells and its level is shown to increase with age in hippocampus and cerebellum. It is also prevalent in embryonic stems cells and its reduced levels are shown to result in impaired self-renewal of stem cells. In the brain and in embryonic stem cells, 5hmC in enriched in promoters, gene bodies, and intergenic areas near genes and positively correlates with gene expression at these loci. 5hmC appears to play a role to promote gene expression during active demethylation. Significantly lower of 5hmC have been reported in cancer cell lines, melanoma, adenomas, and carcinomas compared to the normal surrounding tissue.
免疫原
BSA-conjugated 5-hydroxymethylcytidine.
应用
Anti-5-Hydroxymethylcytosine (5hmC), clone EDL HMC 1A, Cat. No. MABE1093, is a highly specific mouse monoclonal antibody that targets DNA with 5-hydroxymethylcytosine (5hmC) modification and has been tested in Dot Blot and Immunoprecipitation.
Dot Blot Analysis: 0.5 µg/mL from a representative lot detected 0.39-100 ng of DNA with 5-hydroxymethylcytosine (5hmC) modification, but not DNA with only 5-methylcytosine (5mC), 5-formylcytosine (5fC), 5-carboxylcytosine (5caC) modification or unmodified cytosine (Courtesy of Jeong-Heon Lee, Ph.D.; Chad Clark; Tamas Ordog, M.D.; Zhiguo Zhang, Ph.D. Epigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA).
Immunoprecipitation Analysis: 2 µg from a representative lot immunoprecipitated 5 ng of DNA with 5-hydroxymethylcytosine (5hmC) modification, but not DNA with only 5-methylcytosine (5mC), 5-formylcytosine (5fC), 5-carboxylcytosine (5caC) modification or unmodified cytosine (Courtesy of Jeong-Heon Lee, Ph.D.; Chad Clark; Tamas Ordog, M.D.; Zhiguo Zhang, Ph.D. Epigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA).
Immunoprecipitation Analysis: 2 µg from a representative lot immunoprecipitated 5 ng of DNA with 5-hydroxymethylcytosine (5hmC) modification, but not DNA with only 5-methylcytosine (5mC), 5-formylcytosine (5fC), 5-carboxylcytosine (5caC) modification or unmodified cytosine (Courtesy of Jeong-Heon Lee, Ph.D.; Chad Clark; Tamas Ordog, M.D.; Zhiguo Zhang, Ph.D. Epigenomics Development Laboratory, Epigenomics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA).
Research Category
Epigenetics & Nuclear Function
Epigenetics & Nuclear Function
生化/生理作用
Clone EDL HMC 1A targets 5-hydroxymethylcytosine (5hmC), but not 5-methylcytosine (5mC), 5-carboxylcytosine (5caC), 5-formylcytosine (5fC), or unmodified cytosine (C).
Target modification is not species-specific
外形
Protein G purified.
Format: Purified
Purified mouse IgG2b in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
制备说明
Stable for 1 year at 2-8°C from date of receipt.
分析说明
Evaluated by Dot Blot analysis of DNA cytosine modifications.
Dot Blot Analysis: 0.2 µg/mL of this antibody detected 50 ng of DNA with 5-hydroxymethylcytosine (5hmC), but not unmodified DNA or DNA with only 5-methylcytosine (5mC) modification.
Dot Blot Analysis: 0.2 µg/mL of this antibody detected 50 ng of DNA with 5-hydroxymethylcytosine (5hmC), but not unmodified DNA or DNA with only 5-methylcytosine (5mC) modification.
其他说明
Concentration: Please refer to lot specific datasheet.
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
Alfonso Eirin et al.
American journal of physiology. Heart and circulatory physiology, 324(1), H14-H25 (2022-11-12)
Chronic kidney disease (CKD) is common in patients with heart failure and often results in left ventricular diastolic dysfunction (LVDD). However, the mechanisms responsible for cardiac damage in CKD-LVDD remain to be elucidated. Epigenetic alterations may impose long-lasting effects on
Kamalnath S Rajagopalan et al.
Cells, 11(11) (2022-06-11)
Scattered tubular-like cells (STCs) are dedifferentiated renal tubular cells endowed with progenitor-like characteristics to repair injured parenchymal cells. STCs may be damaged and rendered ineffective by renal artery stenosis (RAS), but the underlying processes remain unclear. We hypothesized that RAS
Sara Kazeminia et al.
Clinical science (London, England : 1979), 137(16), 1265-1283 (2023-08-22)
Scattered tubular-like cells (STCs) are differentiated renal tubular cells that during recovery from ischemic injury dedifferentiate to repair other injured renal cells. Renal artery stenosis (RAS), often associated with chronic inflammatory injury, compromises the integrity and function of STCs, but
Alfonso Eirin et al.
Cell death & disease, 15(6), 387-387 (2024-06-02)
Obesity exacerbates tissue degeneration and compromises the integrity and reparative potential of mesenchymal stem/stromal cells (MSCs), but the underlying mechanisms have not been sufficiently elucidated. Mitochondria modulate the viability, plasticity, proliferative capacity, and differentiation potential of MSCs. We hypothesized that
Naba Farooqui et al.
Stem cells (Dayton, Ohio), 41(1), 50-63 (2022-10-18)
Atherosclerotic renal artery stenosis (ARAS) is associated with irreversible parenchymal renal disease and regenerative stem cell therapies may improve renal outcomes. Hypoxia preconditioning (HPC) may improve the regenerative functions of adipose tissue-derived mesenchymal stem cells (AMSC) by affecting DNA 5-hydroxymethylcytosine
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持